Traditional Clomiphene Citrate Administration vs. Stair-step Approach
Information source: University of Oklahoma
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Ovulatory Dysfunction; Anovulation; Ovulation Induction
Intervention: clomiphene citrate (Drug); clomiphene citrate (Drug)
Phase: Phase 3
Status: Recruiting
Sponsored by: University of Oklahoma Official(s) and/or principal investigator(s): LaTasha Craig, MD, Principal Investigator, Affiliation: University of Oklahoma
Overall contact: Michelle Rodriguez, RN, Phone: 405-271-1616
Summary
The purpose of this study is to compare the length of time to achieve ovulation and
pregnancy with a traditional protocol administration of clomiphene citrate versus a stair
step administration.
Our hypothesis is by using a stair-step approach in which a period is not induced between
administrations of escalating doses of clomiphene citrate, the time to ovulation and
pregnancy may be reduced.
Clinical Details
Official title: Traditional Clomiphene Citrate Administration Versus a Stair-Step Approach: A Randomized Controlled Trial
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: Time to ovulation with each protocol
Secondary outcome: Time to pregnancy with each protocolRate of ovulation with each dose of clomid within each protocol Delivery, newborn (within 30 days of birth), and at 1 year of life outcomes
Detailed description:
The traditional administration of clomiphene citrate for ovulation induction involves taking
clomiphene citrate for 5 days. If ovulation does not occur within 14 days, a progestin pill
(such as Provera) is prescribed for 10 days to induce a period (which normally occurs within
1 week of stopping the pill). Then a higher dose of clomiphene citrate will be prescribed.
The stair-step administration of clomiphene citrate for ovulation induction also involves
taking clomiphene citrate for 5 days. In contrast, if ovulation does not occur within 7-9
days, a progestin pill (such as Provera) would NOT be taken to induce a period. The dose of
clomiphene will then be increased. Therefore, this would do away with the 10 days of taking
the progestin pill, and also do away with waiting for a period (usually 3 to 7 days) for a
total of up to a 20 day difference between clomiphene citrate dosing cycles.
Eligibility
Minimum age: 18 Years.
Maximum age: 45 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- Ovulatory dysfunction as evidenced by mid-luteal progesterone less then 3ng/dL,
non-biphasic basal body temperature charting, or menstrual history of cycles > 35
days.
- Female patients 18 to 45 years old
- Six months or greater of unprotected intercourse without pregnancy.
- Normal TSH and prolactin serum levels
- Semen analysis of male partner with > 15 million motile sperm on semen analysis.
- NOTE: Must be willing to travel to the Oklahoma City area for treatment.
Exclusion Criteria:
- Failure to spontaneously menstruate or to menstruate following progestin
administration
- Allergy or intolerance to the side effects of clomiphene citrate, hCG (human
chorionic gonadotropins), or medroxyprogesterone acetate (Provera).
- Known anatomical defect affecting the uterine cavity including submucosal fibroids or
endometrial polyps.
- Know tubal hydrosalpinx or risk factors for tubal obstruction
- Known liver dysfunction
- Known or suspected androgen secreting tumor, cushings disease, or adrenal hyperplasia
(congenital or adult onset)
- Ovarian cyst > 20mm or endometrial lining >6 mm on trans-vaginal baseline ultrasound.
- Stage III or IV endometriosis
- Decreased ovarian reserve as evidenced by antral follicle count less than 6 by
Transvaginal ultrasound or a cycle-day-3 serum FSH of > 10 uIU/ml.
- Positive HIV in either the female patient or her partner.
Locations and Contacts
Michelle Rodriguez, RN, Phone: 405-271-1616
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73013, United States; Recruiting
Additional Information
Starting date: October 2009
Last updated: December 2, 2014
|